“…The detrimental effects that ill-suited, convoluted, or uncertain regulatory frameworks could have on the development, implementation, use, and access of PRSs could also extend to those of other risk assessment tools. One of these tools could be risk prediction models, which can incorporate PRSs combining clinical, biochemical, lifestyle, and historical risk factors to predict 10-year risk of cardiovascular disease, diabetes, or breast/ovarian cancer [ 12 , 40 , 83 , 85 , 110 , 111 , 112 , 113 ]. As such, inappropriate or uncertain regulatory frameworks could prevent patients from having access to available PRSs, risk prediction models, or screening programmes that could enable timely diagnoses that could offer the opportunity to make simple changes in their lifestyles or more moderate adjustments such as diet or exercise instead of undergoing more radical course of action such as surgical procedures or pharmacological interventions [ 83 ].…”